Pacific Biosciences Of California | PACB - Selling And Administration Expenses

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $43.75M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Danaher USD 2.03B 35M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Illumina USD 283M 27M Dec/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Pacific Biosciences Of California USD 43.75M 2.13M Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Standard Biotools USD 26.6M 1.5M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 240.01M 25.78M Dec/2025